Inogen Inc - Asset Resilience Ratio
Inogen Inc (INGN) has an Asset Resilience Ratio of 5.97% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Inogen Inc's Asset Resilience Ratio has changed over time. Check Inogen Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Inogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INGN company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $17.06 Million | 5.97% |
| Total Liquid Assets | $17.06 Million | 5.97% |
Asset Resilience Insights
- Limited Liquidity: Inogen Inc maintains only 5.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Inogen Inc Industry Peers by Asset Resilience Ratio
Compare Inogen Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Inogen Inc (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Inogen Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.31% | $15.85 Million | $298.62 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $296.19 Million | -- |
| 2023-12-31 | 0.91% | $2.98 Million | $326.19 Million | -- |
| 2022-12-31 | 0.00% | $0.00 | $405.04 Million | -- |
| 2021-12-31 | 2.04% | $9.99 Million | $489.51 Million | -2.13pp |
| 2020-12-31 | 4.17% | $19.26 Million | $461.85 Million | +1.70pp |
| 2019-12-31 | 2.47% | $11.06 Million | $447.34 Million | -9.16pp |
| 2018-12-31 | 11.63% | $43.72 Million | $375.90 Million | +0.36pp |
| 2017-12-31 | 11.27% | $30.99 Million | $275.07 Million | +1.44pp |
| 2016-12-31 | 9.83% | $21.03 Million | $214.05 Million | -0.58pp |
| 2015-12-31 | 10.41% | $16.79 Million | $161.31 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $140.09 Million | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more